+919359902383
Levocetirizine & Montelukast Tablets Supplier – Global Pharma Exporter | Ernest Pharmaceuticals
Ernest Pharmaceutical Pvt Ltd is a trusted global exporter of Levocetirizine & Montelukast Tablets, an effective dual-action treatment for asthma, seasonal allergies, allergic rhinitis, and chronic respiratory conditions. Manufactured in WHO-GMP certified facilities, our products meet stringent international quality and safety standards, making them suitable for pharmacy distribution worldwide.

Why Levocetirizine & Montelukast?

Levocetirizine Hydrochloride: Provides rapid relief from symptoms like sneezing, itching, runny nose, and watery eyes.

Montelukast Sodium: Helps prevent asthma attacks, reduces airway inflammation, and controls long-term respiratory conditions.

Combination Advantage: Offers fast allergy relief and long-term respiratory health support in one formulation.

Export Markets We Serve
We supply Levocetirizine & Montelukast Tablets to:

USA – Compliant with FDA standards

UK & Europe – MHRA-compliant packaging

UAE, Saudi Arabia & Middle East – Arabic labeling support

Latin America – Spanish & Portuguese labeling options

Australia, Singapore, Thailand – Stringent quality adherence

Our Commitment to Quality
✔ WHO-GMP Certified Manufacturing
✔ Stringent Quality Control & International Compliance
✔ Custom Packaging & Private Labeling for Distributors

Packaging Options

Standard blister packs (10x10 tablets)

Bulk export packaging

Private labeling as per buyer’s brand

Why Partner with Ernest Pharmaceuticals?

10+ years of global pharma export expertise

Flexible Minimum Order Quantities for bulk orders

Fast & reliable air or sea shipping worldwide

Multiple secure payment options: Wise, SWIFT, Revolut, Western Union, Remitly

Contact for Bulk Orders & Pricing
📧 Email: exports@ernestpharmaceuticals.com
🌐 Websites: www.ernestpharmaceuticals.com | www.ernestimpex.com
📲 WhatsApp: +91 94054 76170

Ernest Pharmaceuticals – Supplying Quality Medicines to 55+ Countries Worldwide

Aug 11th, 2025 5:08 PM

Keywords